# OLANZAPINE
> **ANDA077243** · Abbreviated New Drug Application (Generic) · Sponsor: BARR LABS INC · Approved 2012-01-30
## Drug
- **FDA Application Number:** ANDA077243
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLANZAPINE
- **Generic name:** OLANZAPINE
- **Active ingredients:** OLANZAPINE
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BARR LABS INC
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2012-01-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077243)
---
*AI Analytics · CC0 1.0*